Market revenue in 2023 | USD 2.6 million |
Market revenue in 2030 | USD 15.2 million |
Growth rate | 28.9% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Instruments, Services |
Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 46.15% in 2023. Horizon Databook has segmented the Australia exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Exosomes are used in various applications in the field of research in Australia and professionals are conducting research to determine the potential of exosomes. This trend is further expected to boost the demand for exosomes in the country. In 2017, a research study was performed on analyzing the ability of engineered exosomes to act as vehicles for biologically active proteins.
The study was performed by researchers at The University of Melbourne, Australia; the study concluded that exosomes can be engineered to transport biologically active proteins across the blood-brain barrier. This insight was very crucial in terms of designing therapies associated with brain disorders.
Several companies in Australia offer novel exosome therapies contributing to the revenue generated by the country in the global market. For instance, Regena some Pty Ltd is a headquartered in Melbourne and is focused on designing a novel exosome therapy platform that is based on human amniotic epithelial stem cells; these cells were founded by Monash University and Hudson Institute.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia exosomes market , including forecasts for subscribers. This country databook contains high-level insights into Australia exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account